Diabetic Eye Disease
Bibliographic References tagged with Diabetic Eye Disease
Not finding what you're looking for? Try using Advanced Search.
Not finding what you're looking for? Try using Advanced Search.
Levine R, Myers M, Barunas R, Chang D, Dutta S, Maddess T, Liebmann J, Sherman S, Eydelman M, Sun J, Chambers W, Wickström K, Luhmann U, Pallinat M, Glassman A, Aiello LP, Markel D, Gardner T. Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop.
Transl Vis Sci Technol. 2023;12(11):33. PMID: 38015167
Levine R, Myers M, Barunas R, Chang D, Dutta S, Maddess T, Liebmann J, Sherman S, Eydelman M, Sun J, Chambers W, Wickström K, Luhmann U, Pallinat M, Glassman A, Aiello LP, Markel D, Gardner T. Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop.
Transl Vis Sci Technol. 2023;12(11):33. PMID: 38015167
Ntentakis D, Correa VSMC, Ntentaki AM, Delavogia E, Narimatsu T, Efstathiou N, Vavvas D. Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review.
Graefes Arch Clin Exp Ophthalmol. 2024;262(3):717–752. PMID: 37728754
Ntentakis D, Correa VSMC, Ntentaki AM, Delavogia E, Narimatsu T, Efstathiou N, Vavvas D. Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review.
Graefes Arch Clin Exp Ophthalmol. 2024;262(3):717–752. PMID: 37728754
Ferkowicz M, Verma A, Barwinska D, Ferreira RM, Henderson JM, Kirkpatrick M, Silva P, Steenkamp D, Phillips C, Waikar S, Sutton T, Kidney Precision Medicine Project. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease.
Clin J Am Soc Nephrol. 2023; PMID: 37533147
Ferkowicz M, Verma A, Barwinska D, Ferreira RM, Henderson JM, Kirkpatrick M, Silva P, Steenkamp D, Phillips C, Waikar S, Sutton T, Kidney Precision Medicine Project. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease.
Clin J Am Soc Nephrol. 2023; PMID: 37533147
Aiello LP, Jacoba CM, Ashraf M, Cavallerano J, Tolson A, Tolls D, Sun J, Silva P. Integrating Macular Optical Coherence Tomography with Ultrawide Field Imaging in a Diabetic Retinopathy Telemedicine Program Using a Single Device.
Retina. 2023; PMID: 37418655
Aiello LP, Jacoba CM, Ashraf M, Cavallerano J, Tolson A, Tolls D, Sun J, Silva P. Integrating Macular Optical Coherence Tomography with Ultrawide Field Imaging in a Diabetic Retinopathy Telemedicine Program Using a Single Device.
Retina. 2023; PMID: 37418655
Baldwin G, Vingopoulos F, Garg I, Moon J, Zeng R, Cui Y, Katz R, Le R, Lu E, Sayah D, Hassan Z, Kim L, Elze T, Husain D, Miller J. Structure-function associations between contrast sensitivity and widefield swept-source optical coherence tomography angiography in diabetic macular edema.
Graefes Arch Clin Exp Ophthalmol. 2023;261(11):3113–3124. PMID: 37278906
Baldwin G, Vingopoulos F, Garg I, Moon J, Zeng R, Cui Y, Katz R, Le R, Lu E, Sayah D, Hassan Z, Kim L, Elze T, Husain D, Miller J. Structure-function associations between contrast sensitivity and widefield swept-source optical coherence tomography angiography in diabetic macular edema.
Graefes Arch Clin Exp Ophthalmol. 2023;261(11):3113–3124. PMID: 37278906
Blanco T, Musayeva A, Singh RB, Nakagawa H, Lee S, Alemi H, Gonzalez-Nolasco B, Ortiz G, Wang S, Kahale F, Dohlman T, Chen Y, Dana R. The impact of donor diabetes on corneal transplant immunity.
Am J Transplant. 2023;23(9):1345–1358. PMID: 37245642
Blanco T, Musayeva A, Singh RB, Nakagawa H, Lee S, Alemi H, Gonzalez-Nolasco B, Ortiz G, Wang S, Kahale F, Dohlman T, Chen Y, Dana R. The impact of donor diabetes on corneal transplant immunity.
Am J Transplant. 2023;23(9):1345–1358. PMID: 37245642
Sun J, Glassman A, Maturi R, DRCR Retina Network. Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy-Reply.
JAMA. 2023;329(20):1796. PMID: 37219555
Sun J, Glassman A, Maturi R, DRCR Retina Network. Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy-Reply.
JAMA. 2023;329(20):1796. PMID: 37219555
Wu M, Liu Q, Yu Z, Karvar M, Aoki S, Hamaguchi R, Ma C, Orgill D, Panayi A. Negative-Pressure Wound Therapy Induces Lymphangiogenesis in Murine Diabetic Wound Healing.
Plast Reconstr Surg. 2023;151(4):779–790. PMID: 36729939
Wu M, Liu Q, Yu Z, Karvar M, Aoki S, Hamaguchi R, Ma C, Orgill D, Panayi A. Negative-Pressure Wound Therapy Induces Lymphangiogenesis in Murine Diabetic Wound Healing.
Plast Reconstr Surg. 2023;151(4):779–790. PMID: 36729939
Salongcay R, Jacoba CM, Salva CM, Rageh A, Aquino LA, Saunar A, Alog G, Ashraf M, Peto T, Silva P. One-field, two-field and five-field handheld retinal imaging compared with standard seven-field Early Treatment Diabetic Retinopathy Study photography for diabetic retinopathy screening.
Br J Ophthalmol. 2023; PMID: 37094836
Salongcay R, Jacoba CM, Salva CM, Rageh A, Aquino LA, Saunar A, Alog G, Ashraf M, Peto T, Silva P. One-field, two-field and five-field handheld retinal imaging compared with standard seven-field Early Treatment Diabetic Retinopathy Study photography for diabetic retinopathy screening.
Br J Ophthalmol. 2023; PMID: 37094836
Sun J, Beaulieu W, Melia M, Ferris F, Maturi R, Nielsen J, Solomon S, Jampol L, DRCR Retina Network. DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA.
Retina. 2023;43(4):616–623. PMID: 36728692
Sun J, Beaulieu W, Melia M, Ferris F, Maturi R, Nielsen J, Solomon S, Jampol L, DRCR Retina Network. DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA.
Retina. 2023;43(4):616–623. PMID: 36728692